Thrombosis and Haemostasis

Article	Citations
COVID-19 Patients Putting on the Brakes with PAR1 Autoantibodies	318
Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation	288
Atherosclerotic Autoantigen ALDH4A1 as a Novel Immunological Indicator for Plaque Erosion in Patients with ST Segment Elevated Myocardial Infarction	87
miR-204-5p and Platelet Function Regulation: Insight into a Mechanism Mediated by CDC42 and GPIIbIIIa	79
Rupatadine Treatment Is Associated with Atherosclerosis Worsening and Altered T Lymphocyte Recruitment	68
Characterization of the Role of Integrin α5β1 in Platelet Function, Hemostasis, and Experimental Thrombosis	51
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study	44
	43
Commentary: “No Genetic Causality between Tobacco Smoking and Venous Thromboembolism: A Two-Sample Mendelian Randomization Study”	42
	40
Heparin and Direct Oral Anticoagulants have Different Effects on the Phases of Activation and Spatial Spread of Blood Coagulation	38
	37
Heterogeneity in American and European Peripheral Artery Disease Guidelines on Non-statin Lipid-Lowering Therapy and Rivaroxaban	36
Association between Clot Waveform Analysis Parameters and the Severity of Liver Cirrhosis	35
Clinical and Genetic Characterization of 51 Patients with Congenital Fibrinogen Disorders from China	34
Predictors, incidence, and rate of proximal extension of distal deep vein thrombosis in internal medicine wards: Insights from the AURELIO study.	34
The Effect of Increasing Factor X Levels on Emicizumab-Driven Coagulation Potential	33
Home Treatment Compared to Initial Hospitalization in Normotensive Patients with Acute Pulmonary Embolism in the Netherlands: A Cost Analysis	33
Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis	32
	32
Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment	30
A Rollercoaster Plunge into 2022	29
	29
Volume Regulation and Nonosmotic Volume of Individual Human Platelets Quantified by High-Speed Scanning Ion Conductance Microscopy	29
Obesity and Pulmonary Embolism: Can We Dismantle the “Obesity Paradox”	29

Risk of Ischemic Stroke in Asymptomatic Atrial Fibrillation Incidentally Detected in Primary Care Compared with Other Clinical Presentations	29
3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis	29
Statin Treatment and the Alterations in the Platelet Lipidome: What Is the Impact of Lipid Profile on Thrombosis?	28
Strategies for Tailored Antiplatelet Therapy after Percutaneous Coronary Intervention: Unraveling Complexities, Embracing Nuances	27
Gaining Insights into Inherited Bleeding Disorders of Complex Etiology in Pediatric Patients: Whole-Exome Sequencing as First-Line Investigation Tool	25
Circulating Levels of Low-Density Granulocytes and Cell-Free DNA as Predictors of Cardiovascular Disease and Bone Deterioration in SLE Patients	23
Reflections on World Thrombosis Day 2024	23
Extracorporeal Membrane Oxygenation Induces Early Alterations in Coagulation and Fibrinolysis Profiles in COVID-19 Patients with Acute Respiratory Distress Syndrome	23
Machine Learning-Based Predictive Models for Patients with Venous Thromboembolism: A Systematic Review	23
The Story of the Fibrin(ogen) αC-Domains: Evolution of Our View on Their Structure and Interactions	23
Carotid Stenosis and Stroke: Medicines, Stents, Surgery—“Wait-and-See” or Protect?	22
Cardiac Repair after Myocardial Infarction is Controlled by a Complement C5a Receptor 1-Driven Signaling Cascade	22
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation	21
Open Issues in the Choice and Management of Direct Oral Anticoagulants in Patients with Cancer-Related Venous Thromboembolism	21
Megakaryocyte Cytoskeletal Proteins in Platelet Biogenesis and Diseases	20
Enhancing Pulmonary Embolism Risk Stratification: The National Early Warning Score and Its Integration into the European Society of Cardiology Classification	20
Prognostic Implications of Neutrophil Extracellular Traps in Coronary Thrombi of Patients with ST-Elevation Myocardial Infarction	20
Warfarin—Is Self-Care the Best Care?	19
Circulating Cytokines and Growth Factors in Acute Cerebral Large Vessel Occlusion—Association with Success of Endovascular Treatment	19
Deciding on Treatment Duration for Unprovoked Venous Thromboembolism: What is Important to Patients?	19
Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in France	19
Are More Patients with Thromboembolic Disease Dying Now Than Before?	19
Disseminated Intravascular Coagulation Score Predicts Mortality in Patients with Liver Disease and Low Fibrinogen Level	18
Longitudinal In Vivo Monitoring of Atheroprogression in Hypercholesterolemic Mice Using Photoacoustic Imaging	18
Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study	18
Characterization and Usefulness of Clot-Fibrinolysis Waveform Analysis in Critical Care Patients with Enhanced or Suppressed Fibrinolysis	18
Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia	17
Do Patients with a Family or Personal History of Venous Thromboembolism have an Increased Risk of Recurrence?	17
Dose-Related Effectiveness of Andexanet Alfa for Reversal of Apixaban Anticoagulation in a Porcine Polytrauma Model	17
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials	17
Dual Antiplatelet Therapy or Dual Pathway Inhibition	16
Novel Immunochromatographic Test for Anti-factor XIII B Subunit Autoantibodies to Diagnose Autoimmune Acquired Factor XIII Deficiency	16
Pulmonary Thromboembolism after Catheter Ablation of Cardiac Arrhythmias	16
Anti-thrombotic Effects Mediated by a Novel Dual-Target Peptide Inhibiting Both Platelet Aggregation and Thrombin Activity without Causing Bleeding	16
Clopidogrel Monotherapy versus Aspirin Monotherapy in Patients with Established Cardiovascular Disease: Systematic Review and Meta-Analysis	16
The Prognostic Value of the Age–D-Dimer–Albumin Score in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention	16
Characteristics of the Thrombus Formation in Transgenic Mice with Platelet-Targeted Factor VIII Expression	16
N-Glycosylation Deficiency Reduces the Activation of Protein C and Disrupts Endothelial Barrier Integrity	16
Additional Factor X Enhances Emicizumab-Driven Coagulation Function in Patients with Hemophilia A and Hemophilia A Mice	16
Pregnancy after Combined Oral Contraceptive-Associated Venous Thromboembolism: An International Retrospective Study of Outcomes	15
Emerging Thrombotic Disorders Associated with Virus-Based Innovative Therapies: From VITT to AAV Gene Therapy–Related Thrombotic Microangiopathy	15
Growth Differentiation Factor-15: A Novel Biomarker for Predicting Risk of Venous Thromboembolism and Bleeding in Patients with Cancer	15
Transfer RNAs are Linked to Ischemic Stroke and Major Bleeding in Patients with End-Stage Kidney Disease	15
CLEC-2 Supports Platelet Aggregation in Mouse but not Human Blood at Arterial Shear	15
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS)	15
Hypercoagulability State in Predicting Severe Functional Outcome in Patients with Acute Ischemic Stroke: Cause, Consequence, or Both?	14
Risk Factors for Venous Thromboembolism in Women of Childbearing Age	14
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1B Inhibition Promotes Megakaryocyte Polyploidization and Platelet Production	14
Thrombosis and Haemostasis 2022 Editors' Choice Papers	14
Pathophysiological Aspects of COVID-19-Associated Vasculopathic Diseases	14

Hyperresponsive Platelets and a Reduced Platelet Granule Release Capacity Are Associated with Severity and Mortality in COVID-19 Patients	14
	14
Platelet Surface Protein Expression and Reactivity upon TRAP Stimulation after BNT162b2 Vaccination	14
Sensitivity to Aortic Rupture in Hereditary Aortic Diseases	14
Inhibition of Hypoxia-Inducible Factor Prolyl-Hydroxylase Modulates Platelet Function	13
Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer	13
Association of Combined Lifestyle and Polygenetic Risk with Incidence of Venous Thromboembolism: A Large Population-Based Cohort Study	13
Usual On-therapy Ranges of Drug Concentrations in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants: A Systematic Review and Meta-analysis	13
Continuous Improvement of Antiplatelet Therapy in Cardiovascular Disease	13
Expression of microRNA Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease	13
Cryofibrinogen—Characteristics and Association with Cryoglobulin: A Retrospective Study Out of a Series of 1,712 Samples over 7 Years	13
Gene Abnormalities in Transplant Associated-Thrombotic Microangiopathy: Comparison between Recipient and Donor's DNA	12
Effects of Platelet Agonists and Priming on the Formation of Platelet Populations	12
Clinical Outcomes of Different Warfarin Self-Care Strategies: A Systematic Review and Network Meta-Analysis	12
Current View on the Molecular Mechanisms Underlying Fibrin(ogen)-Dependent Inflammation	12
Inflammatory and Bleeding Risks on Clinical Outcomes in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention	12
Pneumococcal Neuraminidases Increase Platelet Killing by Pneumolysin	11
	11
Growth Differentiation Factor-15, High-Sensitivity Cardiac Troponin T, and N-Terminal pro-B-type Natriuretic Peptide for Predicting Risk of Venous Thromboembolism in Ambulatory Cancer Patients Receivi	11
	11
External Validation of the Patient-Reported Villalta Scale for the Diagnosis of Postthrombotic Syndrome	11
Functional Consequences of Antibodies against Noncatalytic B Subunit of Factor XIII	11
Extravascular Binding of Coagulation Factor IX Gives Hemostasis a Boost	11
	11
SARS-CoV-2 Vaccination: Long-Term Follow-Up of Pre-existing and De Novo Immune Thrombocytopenia	11
COVID-19 and Atrial Fibrillation in Older Patients: Does Oral Anticoagulant Therapy Provide a Survival Benefit?—An Insight from the GeroCovid Registry	11
Antithrombin Resistance Rescues Clotting Defect of Homozygous Prothrombin-Y510N Dysprothrombinemia	10
Compromised PAR1 Activation—A Cause for Bleeding in XMEN?	10
Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis	10
Anticoagulation in Patients with Isolated Distal Deep Vein Thrombosis: Bringing the Puzzle Together	10
Cost-Effectiveness of Performing Reference Ultrasonography in Patients with Deep Vein Thrombosis	10
Kidney Disease and Cancer Risk in Patients with Venous Thromboembolism: What Does It Mean for Clinical Practice?	10
Activation of the Acute-Phase Response in Hemophilia	10
Personalized Medicine, Public Health and Patient-Centred Aspects in the Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation (PRESTIGE-AF) Project	10
Effectiveness and Safety of Apixaban versus Rivaroxaban in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus	10
Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry	10
Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2	10
Emicizumab Dosing in Children and Adults with Hemophilia A: Simulating a User-Friendly and Cost-Efficient Regimen	10
Pharmacokinetics of Edoxaban 15 mg in Very Elderly Patients with Nonvalvular Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Study	10
The Association between Factor XI Deficiency and the Risk of Bleeding, Cardiovascular, and Venous Thromboembolic Events	10
Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype	10
Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)	10
F11 Gene Duplication Causes Elevated FXI Plasma Levels and Is a Risk for Venous Thrombosis	10
Exploring Causal Relationships between Circulating Inflammatory Proteins and Thromboangiitis Obliterans: A Mendelian Randomization Study	10
Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved	10
Optimal Tests to Minimise Bleeding and Ischaemic Complications in Patients on Extracorporeal Membrane Oxygenation	10
Brisk Walking Pace Offsets Venous Thromboembolism Risk Equivalent to Established Monogenic Mutations	10
Vaccine-Induced Immune Thrombotic Thrombocytopenia Two Years Later: Should It Still Be on the Scientific Agenda?	10
Blood Loss in Women of Childbearing Potential Taking Oral Anticoagulants for Venous Thromboembolism (The BLEED Study)	10
Bacterial-Type Long-Chain Polyphosphates Bind Human Proteins in the Phosphatidylinositol Signaling Pathway	10
	9
Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites	9
COVID-19 and Long-COVID Thrombosis: From Clinical and Basic Science to Therapeutics	9
Utility of Sepsis-induced Coagulopathy among Disseminated Intravascular Coagulation Diagnostic Criteria: A Multicenter Retrospective Validation Study	9
Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis	9
High-Resolution Spatial Profiling Unveils Cellular Heterogeneity in Murine Atherosclerosis	9
Not Just CTEPH: A Narrative Review on the Spectrum Approach to Postpulmonary Embolism Conditions	9
Continuous Infusion of Factor VIII and von Willebrand Factor in Surgery: Trials with pdFVIII LFB or pdVWF LFB in Patients with Bleeding Disorders	9
Resting heart rate and risk of incident venous thromboembolism – the Tromsø study	9
Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score	9
Relationship Between Screening-Detected Atrial Fibrillation and Blood Pressure Levels in Elderly Hypertensive Patients: The OMRON Heart Study	9
Validation of Risk Assessment Models Predicting Venous Thromboembolism in Inpatients with Acute Exacerbation Of Chronic Obstructive Pulmonary Disease: A Multicenter Cohort Study in China	9
Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF Trial	9
The Association between Obstructive Sleep Apnea and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study	9
	9
Patterns and Persistence of Anticoagulant Use in the Treatment of Venous Thromboembolism: Insights from South Korea	8
	8
	8
Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects	8
Lack of Formyl-peptide Receptor 1 Mitigates Atherosclerosis in Hyperlipidemic Mice	8
	8
Potential of Sulodexide in the Treatment of Diabetic Retinopathy and Retinal Vein Occlusion	8
Reticulated Platelets: A Promising Prognosis Marker in Cardiovascular Diseases	8
Human Immunodeficiency Virus and Cardiovascular Disease: Revisiting the Inflammation–Thrombosis Axis	8
Joint Effect of Multiple Prothrombotic Genotypes and Obesity on the Risk of Incident Venous Thromboembolism	8
The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper	8
Decline in Overall Pulmonary Embolism-Related Mortality and Increasing Prevalence of Cancer-Associated Events in the Veneto Region (Italy), 2008–2019	8
The Role of Clot Waveform Analysis and Related Parameters in the Diagnosis and Treatment of Hemophilia A	8
Navigating Anticoagulation in Ischemic Left Ventricular Aneurysms: Lessons from Cardiac Magnetic Resonance Imaging	7
Atrial Fibrillation after Cardiac Surgery—To Infinity and Beyond!	7

Elevated Thrombin Generation and Venous Thromboembolism Incidence in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Compared with Minimally Invasive Rectal Su	7
Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial	7
Clopidogrel versus Ticagrelor in CYP2C19 Loss-of-Function Allele Noncarriers: A Real-World Study in China	7
	7
De-escalation of DAPT—A Potential Strategy for Treating Ticagrelor-Related Dyspnea?	7
Pharmacological Inhibition of Glycoprotein VI- and Integrin α2β1-Induced Thrombus Formation Modulated by the Collagen Type	7
Screening for Atrial Fibrillation in Relation to Stroke and Mortality Risk	7
One Year Prevalence of Venous Thromboembolism in Hospitalized COVID-19 Patients in France: Patients' Characteristics, Time Trends, and Outcomes	7
The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study	7
PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison	7
	7
Factor XIII-A Transglutaminase Contributes to Neutrophil Extracellular Trap (NET)-mediated Fibrin(ogen) Network Formation and Crosslinking	7
CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage	7
Platelet Aggregation Is Not Altered in Men with Aortic Aneurysms	7
	7
Viral-Induced Inflammatory Coagulation Disorders: Preparing for Another Epidemic	7
Addendum: Sex as a Risk Factor for Atrial Fibrillation-Related Stroke	7
Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: Fraternal—Not Identical—Twins	7
Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy	7
	7
Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study	7
Hyperfibrinolysis is Associated with Complement Activation Following Trauma	7
A Happy New Year 2024 from Thrombosis and Haemostasis!	7
Neutrophil Extracellular Traps in the Infarct-Related Coronary Artery—A Marker or Mediator of Adverse Outcome?	7
	7
Exploring Pleiotropic Effects of Lipid Modifiers and Targets on Measures of the Coagulation System with Genetics	7
The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease	7
Novel Insights into the Aortic Mechanical Properties of Mice Modeling Hereditary Aortic Diseases	7
Functional Diversity of Primed Platelets—Powered by Machine Learning	7
Educational Attainment, Obesity, and Venous Thromboembolism. Is Only Matter of Weight?	7
Joint Effect of Multiple Prothrombotic Genotypes and Mean Platelet Volume on the Risk of Incident Venous Thromboembolism	6
Adverse Events and All-Cause Mortality in Danish Patients with Cerebral Venous Thrombosis: A Nationwide Cohort Study	6
Increased von Willebrand Factor Platelet-Binding Capacity Is Related to Poor Prognosis in COVID-19 Patients	6
Time Trends and Excess Mortality Compared to Population Controls after a First-Time Pulmonary Embolism or Deep Vein Thrombosis	6
Field Study and Correlative Studies of Factor IX Variant FIX-R338L in Participants Treated with Fidanacogene Elaparvovec	6
Clinical Impact of Dyspnea after Ticagrelor Treatment and the Effect of Switching to Clopidogrel in Patients with Myocardial Infarction	6
	6
An International Consensus Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician: Executive Summary	6
Subclinical Atrial Fibrillation and the Risk of Recurrent Ischemic Stroke	6
Ser252Asn Mutation Introduces a New N-Linked Glycosylation Site and Causes Type IIb Protein C Deficiency	6
C-reactive Protein, Genetic Susceptibility, and the Long-Term Risk of Venous Thromboembolism in Patients with Past Cancer	6
Impact of Fibrinogen Infusion on Thrombin Generation and Fibrin Clot Structure in Patients with Inherited Afibrinogenemia	6
D-β-Hydroxybutyrate Dehydrogenase Mitigates Diabetes-Induced Atherosclerosis through the Activation of Nrf2	6
Stress, Partner Violence, and Coagulopathy: Unmasking New Triggers for Venous Thromboembolism	6
Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with ACS Undergoing PCI: A Systematic Review and Meta-analysis	6
Tetrahydrocurcumin Downregulates MAPKs/cPLA2 Signaling and Attenuates Platelet Thromboxane A2 Generation, Granule Secretion, and Thrombus Growth	6
Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding Risk	6
Concomitant Use of Selective Serotonin Reuptake Inhibitors and Oral Anticoagulants and Risk of Major Bleeding: A Systematic Review and Meta-analysis	6
State-of-the-Art Mini Review: Dual-Pathway Inhibition to Reduce Arterial and Venous Thromboembolism	6
Unravelling the Causal Relationship between Endometriosis and the Risk for Developing Venous Thromboembolism: A Pooled Analysis	6
How Did We Get Here? Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement: A Review	6
Clinical and Laboratory Presentation and Underlying Mechanism in Patients with Low VWF	6
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study	6
Impact of ABO Blood Group on Thromboembolic and Bleeding Complications in Patients with Left Ventricular Assist Devices	6
Structural Conformation and the Binding of Factor VIII R2159C (FVIII-Ise) Mutated in the C1 Domain to Phospholipid	6
Association of Specific Antiphospholipid Antibodies to Platelet Count and Thrombocytopenia	6
Endothelial Progenitor Cells Modulate the Phenotype of Smooth Muscle Cells and Increase Their Neointimal Accumulation Following Vascular Injury	6
Venous Thromboembolism Post-allogeneic Hematopoietic Cell Transplant: Risk Factors, Incidence, and Outcomes	6
Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin	5
	5
An Inhibitory Single-Domain Antibody against Protein Z-Dependent Protease Inhibitor Promotes Thrombin Generation in Severe Hemophilia A and FXI Deficiency	5
	5
Association between Sports Participation, Factor VIII Levels and Bleeding in Hemophilia A	5
DNA Methylation and Ischemic Stroke Risk: An Epigenome-Wide Association Study	5
Sex as a Risk Factor for Atrial Fibrillation-Related Stroke	5
Stability of Rivaroxaban and Apixaban Anti-Xa Activities in Whole Blood Samples: A French Bicentric Study	5
Identification of Factor XIII β-Sandwich Residues Mediating Glutamine Substrate Binding and Activation Peptide Cleavage	5
Methylglyoxal Drives a Distinct, Nonclassical Macrophage Activation Status	5
Racial Differences in Bleeding Risk: An Ecological Epidemiological Study Comparing Korea and United Kingdom Subjects	5
P2Y12 Inhibition Suppresses Proinflammatory Platelet–Monocyte Interactions	5
Factors Influencing Anti-Xa Assays: A Multicenter Prospective Study in Critically Ill and Noncritically Ill Patients Receiving Unfractionated Heparin	5
Reversible Thrombocytopenia of Functional Platelets after Nose-Horned Viper Envenomation is Induced by a Snaclec	5
Causal Effects of COVID-19 on the Risk of Thrombosis: A Two-Sample Mendel Randomization Study	5
HemosIL VWF:GPIbR Assay Has a Greater Sensitivity than VWF:RCo Technique to Detect Acquired von Willebrand Syndrome in Myeloproliferative Neoplasms	5
	5
	5
Venous Thromboembolism Associated with Assisted Reproductive Technology: A Systematic Review and Meta-analysis	5
Selective Serotonin Reuptake Inhibitor Use and Risk of Major Bleeding during Treatment with Vitamin K Antagonists: Results of A Cohort Study	5
Platelet Activation via Glycoprotein VI Initiates Thrombin Generation: A Potential Role for Platelet-Derived Factor IX?	5
Anti-Galectin-2 Antibody Treatment Reduces Atherosclerotic Plaque Size and Alters Macrophage Polarity	5
	4
Proteomics in Thrombosis and Hemostasis	4
Factor Xa Inhibitor Plasma Concentrations and Clinical Outcomes in Patients Weighing ≤50 kg—Experience from Four UK Centers	4
The Hard Bargain of Anticoagulation after Intracranial Hemorrhage, in the Setting of Venous Thromboembolism: Between a Rock and a Hard Place	4
	4
Circulating Blood Biomarkers and Risk of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis	4
Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study	4
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?	4
Endothelial Damage in JAK2V617F Myeloproliferative Neoplasms with Splanchnic Vein Thrombosis	4
Treatment Modifications in Acute Coronary Syndrome Patients Treated with Ticagrelor: Insights from the FORCE-ACS Registry	4
Low α-Thrombin/GPIbα Interaction Is a Potential Contributor to Platelet Hyper-reactivity in COVID-19 Patients	4
Incidence and Outcomes Associated with 6,841 Isolated Distal Deep Vein Thromboses in Patients with 13 Common Cancers	4
Atrial Fibrillation Detected by Single Time-Point Handheld Electrocardiogram Screening and the Risk of Ischemic Stroke	4
Dynamics of Thrombogenicity and Platelet Function and Correlation with Bleeding Risk in Patients Undergoing M-TEER Using the PASCAL System	4
Gene Correction of Wiskott–Aldrich syndrome iPS Cells Rescues Proplatelet Defects and Improves Platelet Size	4